drugset / Trial / NCT01115426

Inhibitors of Angiotensin II in Proteinuric Mesangioproliferative Glomerulonephritis

NCT01115426

Phase 4 Completed 20 enrolled University Magna Graecia
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study evaluates prospectively the effects of an anti-angiotensin II regimen on renal outcome in patients with mesangioproliferative glomerulonephritis followed-up for 10 years.

Timeline

Start
1997-01
Primary completion
2007-01
Completion
2008-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Losartan Other / unclassified 50 mg
Subject Ramipril Small molecule 5 mg